Mark Socinski Named Executive Medical Director at Florida Hospital Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MARK SOCINSKI was named executive medical director of the Florida Hospital Cancer Institute. He will oversee the coordination of clinical cancer services for the Florida Hospital network. He will also be a member of the institute’s Thoracic Oncology Program.

Socinski comes from the University of Pittsburgh Medical Center, where he served as professor of medicine and cardiovascular surgery; director of the Lung Cancer Section for the Division of Hematology and Oncology; co-director of the Lung Cancer Center of Excellence; and co-director of the Lung Cancer Program. Prior to joining UPMC, Socinski served as professor of medicine at the University of North Carolina. His research focuses on clinical trials in thoracic cancers.

YOU MAY BE INTERESTED IN

With the recent FDA approval of daratumumab for high-risk smoldering multiple myeloma, the moment is ripe to revisit the evolution of our understanding of smoldering multiple myeloma. This development not only underscores the growing recognition of early intervention but also invites a broader reflection on the biological insights and therapeutic strategies that have shaped—and continue to shape—this transitional disease state.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login